LinkedIn image ad examples

¿Tiene dificultades con la interpretación de variantes genómicas? Obtenga respuestas de expertos a sus preguntas y soluciones prácticas adaptadas al flujo de trabajo de su laboratorio. Reserve una sesión de formación práctica y gratuita con el equipo de enGenome, del 3 al 6 de noviembre. ¡Reserve su sesión hoy mismo!

Facing challenges with genomic variant interpretation? Get expert answers to your questions and practical solutions tailored to your laboratory’s workflow. Book a free, hands-on training session with the enGenome team, November 3–6.

Build specialist monitoring expertise while creating more space for the people and moments that matter.

Is this You? You naturally care for and nurture others. You are calm, patient, and emotionally steady. You enjoy supporting parents, newborns, and families. You are dependable and professional. You are open to learning, feedback, and mentorship. You can pass a background check and provide strong references.

Learn how life science model-powered patient digital twins can inform study design and more individualized predictions of patient outcomes.

Ready to target root mechanisms of aging? Quercefit™ combines 20x bioabsorption with proven senolytic activity.

A lab result on paper can take hours to trace back through logbooks and printouts. CaliberLIMS keeps every transaction in the audit trail, so a result’s complete history stays in one record. It has supported pharma labs for 20+ years and is designed for 21 CFR Part 11 and EU Annex 11. Learn how CaliberLIMS keeps each result traceable.

Recreating one of the body’s most complex biological environments, the maternal-fetal interface, to understand how disease progresses over time. Dr. Ghorbanpour and her team culture tissue systems dynamically across pregnancy-like timelines instead of studying isolated snapshots. Read the full article and discover more eureka moments.

After production, the batch waits while QA checks every record entry. CaliberBRM flags discrepancies as each step is recorded, so batches reach release sooner. Approvals still run through electronic signatures built to support 21 CFR Part 11. Explore how review by exception works in CaliberBRM.

🌍 Innovative Krebsmedikamente „Made in Germany“ 🏭 Unser hochmodernes Pfizer #Zukunftswerk in Freiburg spielt eine wichtige Rolle bei der #Produktion innovativer Krebstherapien. Sie werden vor Ort produziert und in 185 Länder geliefert: 💪 Das Zukunftswerk ist eine der größten und modernsten Produktionsstätten der pharmazeutischen Industrie – mit automatisierten Verfahren für die flexible und schnelle Herstellung von Medikamenten. 👉 Entdecken Sie, wie in Freiburg medizinische Zukunft entsteht: https://lnkd.in/eEcbanXr #MadeInGermany #Innovation #Onkologie #StarkAmStandort #Fortschritt

Vrijheid, diversiteit en zelfstandigheid: dat is ambulant werken bij CURA XL. Je deelt zelf je agenda in en ondersteunt cliënten met uiteenlopende hulpvragen. Van praktische ondersteuning bij financiën tot externe afspraken en gesprekken over verslaving of psychiatrische problematiek. Die diversiteit vraagt om flexibiliteit, goed overleg en het bewaken van je eigen grenzen. Geen dag is hetzelfde — en juist dat maakt het werk interessant en uitdagend. Benieuwd naar werken bij CURA XL? Bekijk onze website via de link in de reacties! #CURAXL #ambulantezorg #ambulantebegeleiding #werkenindezorg

Exposing tissue to low levels of air pollutants for 96 hours. Bojana and her team at GTOX in Ljubljana are frontrunners in genotoxicity. See how their work with predictive 3D models refined their research. Read the full article and discover more eureka moments

According to people who use MiniMed™ 780G system every day, they enjoy reduced burden compared to other AID systems.¹²

How a mental health service saved 25 hours a week on intake. Screening completed before the appointment, scored automatically.

How a congestive heart failure pathway cut readmissions by 56%. Daily vitals from home, with escalation before the exacerbation rather than after it.

Most kit manufacturers qualify a second Microplate Supplier only after the first one lets them down. I understand why. In an ELISA kit, the plate is a validated raw material. Changing it means revalidating every kit that uses it, so most teams stay with one supplier for years. The problem shows up when that supplier has a bad month. A lot ships late. A code gets discontinued. A formulation changes without anyone asking. At that point you are qualifying an alternative under pressure, with a release date moving and no time to do it properly. The kit manufacturers we talk to are starting this work earlier. They pick a second source while nothing is urgent, test it on their own timeline, and keep it ready. That's the conversation I'd like to have: not "switch today", but "be ready if you need to".

Biomat manufactures High and Medium Binding plates for Immunoassays in Italy, with a direct line to production. 30+ years of Expertise in Surface Modification.

Understanding “which vaccine option would I use” and how vaccines are developed and manufactured adds an important dimension to veterinary education. We welcomed veterinary students nearing the completion of their training to BIOVAC for a seminar exploring the challenges of biological manufacturing, veterinary vaccine development, and broader trends in vaccinology. Visits to several production departments connected these discussions with the processes behind the products. For us, sharing our knowledge is part of supporting the next generation of veterinarians. Bringing students closer to vaccine research and production helps connect their academic training with the scientific expertise and practical considerations that shape veterinary preventive medicine.

DEMO continues to expand its Research and Development activities, strengthening its research capabilities across Attica and Thessaloniki. Our strategic R&D efforts focus on three primary pillars, driving the development of finished pharmaceutical products with a global reach, the production of Active Pharmaceutical Ingredients (APIs), and our expansion into Biotechnology. Anchored by our R&D Center in Thessaloniki and 9 state-of-the-art laboratories, we target the annual development of 5 new active ingredients and 21 finished products, further solidifying our presence across European and US markets. #DemoSA #AlwaysForward #Biotechnology #ResearchAndDevelopment #GreekPharma

Would you like to discover how high-relaxivity contrast agents and AI can impact on CNS and brain MRI? Reserve your seat to this webinar ‘Advancing Neuro MRI: High Relaxivity contrast agents and the Potential of Contrast Boosting Software in Routine Practice’ on October 22 at 6:00 p.m CEST. The webinar is organized in partnership with European Society of Neuroradiology, where a panel of leading experts in neuroradiology, Andrea Rossi, Peter Schramm, Bronwyn Hamilton, and Gunter Erb will discuss the benefits and clinical relevance of high-relaxivity contrast agents in routine practice, as well as the potential of Bracco contrast boosting software to enhance brain imaging by improving image quality and amplifying contrast enhancement. The webinar will also feature a live Q&A session, giving attendees the opportunity to engage directly with the faculty. 🎬 Discover more on ESNR page https://lnkd.in/ewHdAuHV and on our website, where you can watch the 2-minutes video teaser with all the faculty: https://lnkd.in/drJCJViC #BraccoImaging #MRI #Webinar #BrainMRI #ESNR

𝐀𝐭 𝐀𝐠𝐫𝐨𝐧𝐨𝐯𝐚 𝐁𝐢𝐨𝐭𝐞𝐜𝐡, 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐢𝐬 𝐧𝐨𝐭 𝐚𝐧 𝐨𝐩𝐭𝐢𝐨𝐧 𝐛𝐮𝐭 𝐭𝐡𝐞 𝐩𝐚𝐭𝐡 𝐟𝐨𝐫𝐰𝐚𝐫𝐝. That’s why we integrate 𝐦𝐞𝐭𝐚𝐠𝐞𝐧𝐨𝐦𝐢𝐜 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 as a strategic part of our R&D activities, driving the development of more effective, sustainable, and science-based agricultural solutions. Metagenomics allows us to deeply and accurately study the 𝐦𝐢𝐜𝐫𝐨𝐛𝐢𝐨𝐦𝐞𝐬 𝐩𝐫𝐞𝐬𝐞𝐧𝐭 𝐢𝐧 𝐚𝐠𝐫𝐢𝐜𝐮𝐥𝐭𝐮𝐫𝐚𝐥 𝐞𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭𝐬 -from soils to plant tissues- without the need to isolate or culture microorganisms. This opens a unique window into the microbial world interacting with crops, helping us to: 🌱 Identify 𝐛𝐞𝐧𝐞𝐟𝐢𝐜𝐢𝐚𝐥 𝐦𝐢𝐜𝐫𝐨𝐛𝐢𝐚𝐥 𝐜𝐨𝐦𝐦𝐮𝐧𝐢𝐭𝐢𝐞𝐬 that support plant health. 🦠 Characterize 𝐤𝐞𝐲 𝐦𝐢𝐜𝐫𝐨𝐛𝐢𝐚𝐥 𝐬𝐭𝐫𝐚𝐢𝐧𝐬 in our products (such as 𝘉𝘢𝘤𝘪𝘭𝘭𝘶𝘴 ) and validate their persistence and functionality under field conditions. 🧬 Develop more 𝐭𝐚𝐫𝐠𝐞𝐭𝐞𝐝 𝐚𝐧𝐝 𝐞𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞 𝐟𝐨𝐫𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬, based on real ecosystem data from agricultural systems. 📊 Monitor the 𝐦𝐢𝐜𝐫𝐨𝐛𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐢𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐨𝐮𝐫 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 in real time with molecular-level precision. Our advanced bioinformatics tools generate comprehensive reports on microbial diversity, enabling our agronomists to assess soil and plant health and provide more 𝐚𝐜𝐜𝐮𝐫𝐚𝐭𝐞 𝐫𝐞𝐜𝐨𝐦𝐦𝐞𝐧𝐝𝐚𝐭𝐢𝐨𝐧𝐬 for sustainable nutrition and biostimulation strategies. This approach also provides a powerful tool for 𝐭𝐫𝐚𝐜𝐤𝐢𝐧𝐠 the performance of biofertilizers and biostimulants in crop systems.

ApolloMD found $46.6M in downcoded payments. On claims that were already marked paid. Turns out "paid in full" had a lot of asterisks. Grab the case study in the Financial Performance neighborhood at Thrive, or read more now.

It costs between $800K and $2.3M to replace a single physician. At a Top 20 U.S. health system, turnover dropped 30% after rolling out Atalan. On one 169-provider campus, rolling 12-month turnover dropped from 7.9% to 5.6%, about four more providers retained and an estimated $2.37 million in value. Early results helped support expanding Atalan to more than 1,400 clinicians across five sites. Request an invitation to our October 22 dinner conversation in Scottsdale, or get the case study.

Join Dr. Sisi Hu, Atalan's chief economist, and peer physician leaders on October 22 for a dinner conversation on why physicians leave. She'll share what her latest research shows about the signals that come before a resignation, and what leaders can do first. The dinner is in Scottsdale during AAPL 2026, hosted by Atalan. Request an invitation, and our team follows up by email. Can't make it? You'll still get her findings.